Old Drugs, New Tricks: Remdesivir and Other Potential Treatments for COVID19

The video discusses Remdesivir, an antiviral drug developed by Gilead Sciences, initially for hepatitis C and Ebola. It shows potential against coronaviruses, including COVID-19, by targeting viral replication mechanisms. Various studies, including those by Gilead and NIAID, indicate it may reduce recovery time but not mortality rates. The drug is approved for emergency use in some countries, but more research is needed to confirm its efficacy and safety.

What are the limitations of the studies conducted on Remdesivir as mentioned in the text?

What does the data suggest about the timing of administering Remdesivir in relation to its effectiveness?

What is the current status of Remdesivir's approval for use in different countries?